By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Catalyst Pharmaceutical Partners, Inc. 

355 Alhambra Circle, Suite 1500

Coral Gables  Florida  33134  U.S.A.
Phone: 305-529-2522 Fax: 305-529-0933



Company News
Catalyst Pharma (CPRX) To Present At 15th Annual BIO Investor Forum 10/13/2016 7:55:41 AM
Catalyst Pharma (CPRX) Announces Publication Of CPP-115 Clinical Efficacy Data For Infantile Spasms In Epilepsy & Behavior Case Reports 9/19/2016 7:54:25 AM
Catalyst Pharma (CPRX) Announces Launch Of Expanded Access Program Website And Participation At The American Association Of Neuromuscular & Electrodiagnostic Medicine Conference 9/14/2016 7:47:47 AM
Catalyst Pharma (CPRX) To Present At Rodman & Renshaw’s 18th Annual Global Investment Conference 9/8/2016 7:58:56 AM
Catalyst Pharma (CPRX) Announces FDA Orphan Drug Designation Of Firdapse For The Treatment Of Myasthenia Gravis 9/6/2016 8:02:33 AM
Catalyst Pharma (CPRX) Announces Second Quarter 2016 Financial Results And Provides Product Development Update 8/10/2016 10:37:58 AM
Catalyst Pharma (CPRX) To Hold Second Quarter Financial Results And Corporate Update Conference Call And Webcast On Wednesday, August 10th, 2016 8/1/2016 10:39:12 AM
Catalyst Pharma (CPRX) Announces Agreement With FDA On Confirmatory Phase III Study Protocol For Firdapse In Lambert-Eaton Myasthenic Syndrome 6/13/2016 7:53:34 AM
Catalyst Pharma (CPRX) To Present At The Jefferies 2016 Healthcare Conference 6/1/2016 8:19:18 AM
Catalyst Pharma (CPRX)’s Firdapse Phase III Study Published In Muscle & Nerve 5/18/2016 7:54:05 AM